Assistant Professor of Oncology, Department of Pharmacology and Therapeutics, Roswell Park Cancer Institute, Buffalo, NY, USA
Institute of Cancer Therapeutics University of Bradford, UK.
Associate Professor,Faculty of Pharmacy,Department Of Pharmacology and Therapeutics,Kuwait University.
Harvard Medical School Chief, Division of Translational Therapeutics, Department of Medicine, Director of Translational Therapeutics, Cancer Research Institute, United States.
Formulation Scientist at Insys Therapeutics
Senior Research Associate, Department of Therapeutic Endocrinology, Endocrinology Research Center, Moscow, Russia
Senior Scientist/Pre-Clinical Manager, Repros Therapeutics, The Woodlands, TX
Diagnostic and Therapeutic Technologies Department, School of Health Sciences - Polytechnic Institute of Bragança, Portugal
Ph.D. in Pharmaceutical Sciences, Formulation Scientist, Insys Therapeutics, University of Nebraska Medical Center, USA
Department of Clinical and Experimental Therapeutics, University of Georgia, Augusta, USA
Postdoctoral research Fellow in the Department of Neurology and Neurotherapeutics at University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Assistant Professor in the Department of Molecular Pharmacology and Therapeutics of Loyola University Chicago, USA.
Author(s): Dagmar Pretsch1, Luiz C. Klein-Junior2, Sylvian Cretton3, Philippe Christen3, Amélia T. Henriques4 and Judith M. Rollinger1
Author(s): M. Michael Bercu
Author(s): Sara Rosa De Sousa Andrade
Author(s): Muralidharan Velappan and Deecaraman Munusamy
Author(s): Khattab Al-Khafaji, Tugba Taskin-Tok, Zafer Cetin, Eyup Ilker Saygili, Selin Sayın, Sinem Ugur, Merve Goksin Karaaslan, Oral Cenk Aktas, Esra Küpeli Akkol* and Haroon Khan